| CARD ID | 1450 | |
| Type of strain | Targeted mutant. | |
| Strain name | B6;129Sv-Ptgs2tm1Hrh | |
| Internal Code | Ptgs2tm1Hrh (Cox-2flox) | |
| Submitter | Tomo-o Ishikawa - | |
| Submitter affiliation or code | Department of Pharmacology,UCLA | |
| Stock Type | ||
| Material Transfer Conditions |
|
|
| Production method | in-house breeding | |
| Origin (In-house) | Organization | UCLA |
| Organization code | ||
| Developer | Hervey Herschman, Tomo-o Ishikawa | |
| Origin (From other organizations) | Organization | |
| Organization code | ||
| Developer | ||
| Year introduced | ||
| Introduced Generation | ||
| Remarks | ||
| Gene symbol | Ptgs2 |
| Gene name | prostaglandin-endoperoxide synthase 2 (synonym for cyclooxygenase 2) |
| Allele symbol | Ptgs2tm1Hrh |
| Allele name | prostaglandin-endoperoxide synthase 2; targeted mutation 1, UCLA |
| MGI | |
| Chromosome | 1 (63.84) , |
| Gene classification | Targeted or trapped gene(knockout etc.) |
| Method | Electroporation |
| OMIM |
| Cox2I3F1 | AAA GTT CAG CCA TTG TAC AGC AGG G AGC |
| Cox2E4R2 | AGA AGG CTT CCC AGC TTT TGT AAC C |
| Disease name, Applicable field | Physiology, cancer, Neurobiology |